Hoberman Kenneth bought TGTX
June 12, 2025 · Form 4 insider transaction
Hoberman Kenneth bought 14,718 shares of TG Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,718
Price
$0.00
Total value
N/A
InsiderHoberman Kenneth
Role—
CompanyTG Therapeutics, Inc. (TGTX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 12, 2025
Filing dateJune 16, 2025
Shares owned after279,653
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects a grant of restricted shares that will vest on June 12, 2026.; Includes shares of restricted Common Stock, which vest over various time periods.